IRIS
DI MINNO, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 12.790
NA - Nord America 10.770
EU - Europa 7.332
SA - Sud America 1.647
Continente sconosciuto - Info sul continente non disponibili 755
AF - Africa 310
OC - Oceania 19
Totale 33.623
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.234
SG - Singapore 6.396
RU - Federazione Russa 3.582
CN - Cina 2.006
VN - Vietnam 1.968
BR - Brasile 1.338
HK - Hong Kong 1.309
IT - Italia 894
DE - Germania 495
FI - Finlandia 495
FR - Francia 495
CA - Canada 294
IE - Irlanda 271
NL - Olanda 227
UA - Ucraina 212
GB - Regno Unito 190
JP - Giappone 180
SE - Svezia 173
BD - Bangladesh 161
IN - India 158
MX - Messico 123
AR - Argentina 121
IQ - Iraq 99
ZA - Sudafrica 78
ES - Italia 65
PH - Filippine 65
CI - Costa d'Avorio 55
PK - Pakistan 55
ID - Indonesia 52
KR - Corea 52
PL - Polonia 51
EC - Ecuador 48
TH - Thailandia 43
AT - Austria 39
CO - Colombia 37
TW - Taiwan 35
TR - Turchia 34
MA - Marocco 24
CL - Cile 23
JM - Giamaica 23
SA - Arabia Saudita 22
UZ - Uzbekistan 22
VE - Venezuela 22
EG - Egitto 20
PY - Paraguay 19
JO - Giordania 18
KE - Kenya 17
PE - Perù 17
TN - Tunisia 16
NP - Nepal 15
BG - Bulgaria 14
AE - Emirati Arabi Uniti 13
CH - Svizzera 13
CZ - Repubblica Ceca 13
SN - Senegal 12
GT - Guatemala 11
NI - Nicaragua 11
RO - Romania 11
BE - Belgio 10
CR - Costa Rica 10
RS - Serbia 10
TT - Trinidad e Tobago 10
UY - Uruguay 10
DO - Repubblica Dominicana 9
ET - Etiopia 9
AO - Angola 8
AU - Australia 8
BO - Bolivia 8
DZ - Algeria 8
EU - Europa 8
HN - Honduras 8
AZ - Azerbaigian 7
BB - Barbados 7
GR - Grecia 7
IR - Iran 7
KZ - Kazakistan 7
NG - Nigeria 7
HU - Ungheria 6
IL - Israele 6
LT - Lituania 6
LU - Lussemburgo 6
MY - Malesia 6
PT - Portogallo 6
SV - El Salvador 6
EE - Estonia 5
GH - Ghana 5
LC - Santa Lucia 5
MN - Mongolia 5
PA - Panama 5
BA - Bosnia-Erzegovina 4
BF - Burkina Faso 4
CY - Cipro 4
HR - Croazia 4
KG - Kirghizistan 4
KW - Kuwait 4
LA - Repubblica Popolare Democratica del Laos 4
ML - Mali 4
NC - Nuova Caledonia 4
OM - Oman 4
PS - Palestinian Territory 4
Totale 32.755
Salva come PNG Salva come JPEG
Città #
Singapore 2.736
San Jose 1.750
Hong Kong 1.264
Moscow 852
Chandler 613
Ashburn 599
Ho Chi Minh City 563
Santa Clara 494
The Dalles 476
Hanoi 455
Princeton 445
Beijing 429
Boston 394
Lauterbourg 391
Millbury 380
Los Angeles 275
Nanjing 274
Amsterdam 203
Jacksonville 199
Hefei 187
Buffalo 184
Naples 159
Ottawa 156
Tokyo 147
Council Bluffs 145
Wilmington 144
São Paulo 129
Redondo Beach 125
New York 116
Napoli 109
Des Moines 100
Munich 96
Haiphong 89
Nanchang 89
Boardman 87
Dallas 87
Da Nang 83
Menlo Park 80
Seattle 69
Hebei 67
Shenyang 63
Falls Church 61
Mexico City 60
Norwalk 60
Orem 60
Houston 59
Turku 55
Nuremberg 54
Tianjin 50
Chicago 47
Jiaxing 47
Rome 45
Brooklyn 44
Warsaw 44
Frankfurt am Main 43
Baghdad 41
Denver 39
Milan 37
Montreal 37
Johannesburg 36
San Francisco 36
Rio de Janeiro 35
Atlanta 33
Changsha 33
Hải Dương 32
Chennai 31
Stockholm 30
Biên Hòa 29
Phoenix 28
Dublin 27
Toronto 27
Kronberg 26
Helsinki 25
Brasília 24
Can Tho 24
Curitiba 24
Kerken 24
Dhaka 23
Krefeld 23
Lawrence 22
Nocera Inferiore 22
Seoul 22
Woodbridge 22
London 21
Castellón 20
Tashkent 20
Manchester 19
Redwood City 19
Vienna 19
Guayaquil 18
Thái Nguyên 18
Amman 17
Ann Arbor 17
Bangkok 17
Ribeirão Preto 17
Belo Horizonte 16
Kunming 16
Philadelphia 16
Redmond 16
Campinas 15
Totale 17.145
Salva come PNG Salva come JPEG
Nome #
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 234
Perspective - The case for zero bleeds and drug bioequivalence in the treatment of congenital hemophilia A in 2021 202
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 199
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 197
111° Congresso SIMI 193
New data from the italian national register of congenital coagulopathies, 2016 annual survey 176
Spontaneous Muscle Hematoma in Patients with COVID-19: A Systematic Literature Review with Description of an Additional Case Series 161
Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study 149
Long-lasting intestinal bleeding in an old patient with multiple mucosal vascular abnormalities and Glanzmann's thrombasthenia: 3-year pharmacological management. 141
Anticoagulant Therapy in Oncologic Patients Undergoing Venous Stenting for Superior Vena Cava Syndrome and Other Interventional Procedures. 140
“A fast and accurate method for genotyping the Angiotensin-Converting Enzyme (ACE) I/D polymorphism” 138
Perioperative handling of patients on antiplatelet therapy with need for surgery. 137
Right-to-left shunt, atrial septal aneurysm and thrombophilia in patients with cryptogenic stroke or TIA vs. those with venous thrombo-embolism 136
Aberrant F8 gene intron 1 inversion with concomitant duplication and deletion in a severe hemophilia A patient from Southern Italy. 134
RASopathies and hemostatic abnormalities: key role of platelet dysfunction 133
Antiphospholipid syndrome, adrenal failure, dilated cardiomyopathy and chronic hepatitis: an unusual manifestation of multiorgan autoimmune injury? 133
Endothelin abnormalities in patients with pulmonary embolism. 130
Risk factors and recurrent thrombotic episodes in patients with cerebral venous thrombosis 130
Acquired Factor v Inhibitor after Coronavirus Disease 2019 (COVID-19) 130
Haemophilia A: molecular insights. 129
Diabetes,vascular complications and antiplatelet therapy: open problems 127
Antithrombotic drugs, patient characteristics, and gastrointestinal bleeding: Clinical translation and areas of research 127
Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia 127
Acquired haemophilia a in the elderly: case reports. 126
The infectious burden in atherothrombosis. 126
The challenge of diagnosing pulmonary embolism in children, pregnant women, and elderly patients: a descriptive review of the literature. 126
Oxidative stress and plateletactivation in homozygous homocystinuria 125
The risk of gastrointestinal bleeding in patients receiving dabigatran etexilate: a systematic review and meta-analysis of the literature 125
Emergency management in patients with haemophilia A and inhibitors on prophylaxis with emicizumab: AICE practical guidance in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET 125
Mutational spectrum of F8 gene and prothrombotic gene variants in haemophilia A patients from Southern Italy. 123
Venous thromboembolism in covid-19 compared to non-covid-19 cohorts: A systematic review with meta-analysis 123
Acute coronary syndrome and severe haemophilia: an unusual association with challenging treatment. 122
A fast and accurate method for genotyping the angiotensin-converting enzyme I/D polymorphism. 120
HELLP syndrome and its relation with the antiphospholipid syndrome. 120
Benefits of prophylaxis versus on-demand treatment in adolescents and adults with severe haemophilia A: The POTTER study 120
ANMCO Position Paper: Long-term follow-up of patients with pulmonary thromboembolism 120
Cardiac Manifestations of Antiphospholipid Syndrome: Clinical Presentation, Role of Cardiac Imaging, and Treatment Strategies 120
Can serum TGF-beta 1 be used to evaluate the response to antiviral therapy of haemophilic patients with HCV-related chronic hepatitis? 119
Hemostatic variables in homozygous familial hypercholesterolemia. Effect of regular plasma cholesterol removal by low density lipoprotein apheresis. 119
Predicting early and delayed bleedings in children who undergo adeno-tonsillectomy surgery. Is it really possible? 119
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII 118
Awareness of individual goals, preferences, and priorities of persons with severe congenital haemophilia A for a tailored shared decision-making approach to liver-directed gene therapy. A practical guideline 117
Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: a review of the literature. 117
Methylation reactions, the redox balance and atherothrombosis: the search for a link with hydrogen sulfide 117
Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications 116
Improving assessment and management of pain in hemophilia: an Italian Delphi consensus statement 116
Denaturing HPLC procedure for factor IX gene scanning 115
Absence of apolipoprotein B3500 mutation in type 2a hyperlipoproteinemia patients and in the general population from southern Italy. 115
[Absence of an association of the D allele of the ACE gene with arterial pressure in mild-moderate essential arterial hypertension]. 115
Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease. 115
Neutrophil extracellular traps as an adhesion substrate for different tumor cells expressing RGD-binding integrins. 113
Attempting to remedy sub-optimal medication adherence in haemophilia: The rationale for repeated ultrasound visualisations of the patient's joint status 113
Paradigm shift for the treatment of hereditary haemophilia: Towards precision medicine 113
The first ambulatory screening on thromboembolism: a multicentre, cross-sectional, observational study on risk factors for venous thromboembolism. 111
Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: A systematic review and meta-analysis 111
Gastrointestinal bleeding in patients receiving oral anticoagulation: Current treatment and pharmacological perspectives 111
Diabetes mellitus and cardiovascular prevention: the role and the limitations of currently available antiplatelet drugs. 110
I nuovi anticoagulanti orali: Raccomandazioni, precauzionie prospettive d'uso 110
Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis 110
Natural anticoagulants deficiency and the risk of venous thromboembolism: A meta-analysis of observational studies 109
Comparative analysis of the pivotal studies of extended half-life recombinant FVIII products for treatment of haemophilia A 109
Venous thromboembolism: which patients are truly at risk? 108
Low Rate of Intrahospital Deep Venous Thrombosis in Acutely Ill Medical Patients: Results From the AURELIO Study 106
The "antiphospholipid triangle" in an asymptomatic patient: a case report. 106
Ensuring medication adherence with direct oral anticoagulant drugs: lessons from adherence with vitamin K antagonists (VKAs). 106
Left ventricular diastolic abnormalities other than valvular heart disease in antiphospholipid syndrome: An echocardiographic study 106
Aspirin for preventing the recurrence of venous thromboembolism. 105
Thrombosis in Autoimmune Diseases: A Role for Immunosuppressive Treatments? 105
The risk of venous thromboembolism in patients with cirrhosis. A systematic review and meta-analysis 105
Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke: an Italian Case-Control Study 104
ABNORMALLY HIGH THROMBOXANE BIOSYNTHESIS IN HOMOZYGOUS HOMOCYSTINURIA. EVIDENCE FOR PLATELET INVOLVEMENT AND PROBUCOL-SENSITIVE MECHANISM. 104
Transient global amnesia in a young woman on prolonged treatment with oral contraceptive drugs. 104
Carotid intima-media thickness in psoriatic arthritis: Differences between tumor necrosis factor-α blockers and traditional disease-modifying antirheumatic drugs 103
Arthropathy in patients with moderate hemophilia A: A systematic review of the literature 103
Molecular analysis and genotype-phenotype correlation in patients with antithrombin deficiency from Southern Italy. 101
Consensus statements on vaccination in patients with haemophilia—Results from the Italian haemophilia and vaccinations (HEVA) project 101
Serum concentrations of the tissue polypeptide specific antigen in patients suffering from non-alcoholic steatohepatitis 100
The real effectiveness of ultrasound guidance in subclavian venous access. 100
Noninvasive assessment of liver fibrosis in patients with chronic hepatitis C (and congenital bleeding disorders): where do we stand? 100
Improving the use of direct oral anticoagulants in atrial fibrillation 100
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry 100
Uncomplicated type 1 diabetes and preclinical left ventricular myocardial dysfunction: insights from echocardiography and exercise cardiac performance evaluation. 98
Cost of care of haemophilia with inhibitors. 98
Nutrition, Metabolism, Cardiovascular Disease 98
Pain assessment and management in Italian Haemophilia Centres 98
Cardiovascular Risk in Rheumatic Patients: The Link between Inflammation and Atherothrombosis. 96
Diabetes and cardiovascular disease: Thrombotic risk and aspirin-resistance. 95
Insight into the nature of the CRP-coronary event association using Mendelian randomization. 94
Management of ischemic heart disease in hemophiliac patients: new challenges from a case report and review of the literature 93
“Structural and functional cardiovascular abnormalities in never-treated hypertensives according to ACE-gene polymorphism” 93
Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke. 93
Association of TERC and OBFC1 haplotypes with mean leukocyte telomere length and risk for coronary heart disease. 93
From unfractionated heparin to pentasaccharide: Paradigm of rigorous science growing in the understanding of the in vivo thrombin generation 93
Increased binding of fibrinogen to platelets in diabetes: the role of prostaglandins and thromboxane. 92
Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy 92
Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells 92
Italian intersociety consensus on DOAC use in internal medicine 92
Physical activity improved by adherence to prophylaxis in an Italian population of children, adolescents and adults with severe haemophilia A: The SHAPE Study 92
Factor V Leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia. 91
A role for von Willebrand factor in immune tolerance induction in patients with haemophilia A and inhibitors? 90
Totale 11.812
Salva come PNG Salva come JPEG
Categoria #
all - tutte 122.881
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.881
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.834 0 8 2 5 11 30 21 76 274 107 188 1.112
2022/20231.787 480 88 28 116 168 154 1 177 286 177 94 18
2023/20241.323 39 195 169 67 35 26 106 96 10 7 383 190
2024/20259.125 603 895 22 92 98 324 852 466 1.296 1.005 2.659 813
2025/202615.538 1.883 1.043 1.399 1.290 2.733 676 1.727 956 2.237 996 307 291
2026/2027667 372 295 0 0 0 0 0 0 0 0 0 0
Totale 33.623